Ken Getz

406 total citations
20 papers, 234 citations indexed

About

Ken Getz is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Pharmacology. According to data from OpenAlex, Ken Getz has authored 20 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 7 papers in Economics and Econometrics and 4 papers in Pharmacology. Recurrent topics in Ken Getz's work include Ethics in Clinical Research (8 papers), Pharmaceutical industry and healthcare (4 papers) and Health and Medical Research Impacts (4 papers). Ken Getz is often cited by papers focused on Ethics in Clinical Research (8 papers), Pharmaceutical industry and healthcare (4 papers) and Health and Medical Research Impacts (4 papers). Ken Getz collaborates with scholars based in United States, United Kingdom and France. Ken Getz's co-authors include Michael Wilkinson, Bruce A. Donzanti, R. Wilkins, Jeremy Sugarman, Jeanne L. Speckman, Margaret M. Byrne, Deborah Howe, Craig Morgan, John McCormick and Richard W. Young and has published in prestigious journals such as SHILAP Revista de lepidopterología, Academic Medicine and Clinical Therapeutics.

In The Last Decade

Ken Getz

18 papers receiving 217 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ken Getz United States	9	84	44	43	32	27	20	234
Scott Askin Switzerland	5	76 0.9×	50 1.1×	23 0.5×	38 1.2×	32 1.2×	5	287
Hui–Hsing Wong United States	5	81 1.0×	122 2.8×	18 0.4×	41 1.3×	53 2.0×	7	350
Hanzhe Zhang China	5	33 0.4×	81 1.8×	22 0.5×	53 1.7×	15 0.6×	8	273
G. Caleb Alexander United States	8	54 0.6×	169 3.8×	27 0.6×	45 1.4×	22 0.8×	11	391
Nigel Hughes United Kingdom	7	38 0.5×	38 0.9×	14 0.3×	24 0.8×	22 0.8×	14	187
Jonas Häggström Canada	7	31 0.4×	28 0.6×	9 0.2×	29 0.9×	19 0.7×	8	218
Arturo López Pineda United States	8	59 0.7×	52 1.2×	15 0.3×	82 2.6×	8 0.3×	16	366
Eugenia McPeek Hinz United States	7	90 1.1×	19 0.4×	21 0.5×	67 2.1×	84 3.1×	20	342
Susanne Wieschowski Germany	10	112 1.3×	28 0.6×	12 0.3×	30 0.9×	21 0.8×	15	263
Brian McCourt United States	6	312 3.7×	42 1.0×	18 0.4×	94 2.9×	29 1.1×	8	585

Countries citing papers authored by Ken Getz

Since Specialization

Citations

This map shows the geographic impact of Ken Getz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Getz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Getz more than expected).

Fields of papers citing papers by Ken Getz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Getz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Getz. The network helps show where Ken Getz may publish in the future.

Co-authorship network of co-authors of Ken Getz

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Getz. A scholar is included among the top collaborators of Ken Getz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Getz. Ken Getz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Jennifer Y., et al.. (2024). The influence of socioeconomic status on individual attitudes and experience with clinical trials. SHILAP Revista de lepidopterología. 4(1). 172–172. 9 indexed citations

Snowdon, Jane, et al.. (2021). Characterizing Pain Points in Clinical Data Management and Assessing the Impact of Mid-Study Updates. Therapeutic Innovation & Regulatory Science. 55(5). 1006–1012. 1 indexed citations

Wilkinson, Michael, et al.. (2020). Evolving Clinical Data Strategies and Tactics in Response to Digital Transformation. Therapeutic Innovation & Regulatory Science. 55(2). 272–281. 1 indexed citations

Wilkinson, Michael, et al.. (2020). Assessing Outsourcing Oversight Practices and Performance. Therapeutic Innovation & Regulatory Science. 54(1). 158–166.

Wilkinson, Michael, et al.. (2019). A Study on the Application and Use of Artificial Intelligence to Support Drug Development. Clinical Therapeutics. 41(8). 1414–1426. 87 indexed citations

Getz, Ken, et al.. (2019). Using Patient Advisory Boards to Solicit Input Into Clinical Trial Design and Execution. Clinical Therapeutics. 41(8). 1408–1413. 8 indexed citations

Getz, Ken, et al.. (2019). Assessing the adoption of clinical trial results summary disclosure to patients and the public. Expert Review of Clinical Pharmacology. 12(7). 573–578. 10 indexed citations

Wilkinson, Michael, et al.. (2018). Assessing Study Start-up Practices, Performance, and Perceptions Among Sponsors and Contract Research Organizations. Therapeutic Innovation & Regulatory Science. 52(5). 572–578. 14 indexed citations

Wilkinson, Michael, et al.. (2018). Baseline Assessment of the Evolving 2017 eClinical Landscape. Therapeutic Innovation & Regulatory Science. 53(1). 71–80. 13 indexed citations

10.

McCormick, John, et al.. (2018). The Use of Real-World Evidence and Data in Clinical Research and Postapproval Safety Studies. Therapeutic Innovation & Regulatory Science. 52(6). 778–783. 18 indexed citations

11.

Brothers, Cindy, et al.. (2013). Benchmarking the Study Initiation Process. Therapeutic Innovation & Regulatory Science. 47(1). 101–109. 13 indexed citations

12.

Howe, Deborah, et al.. (2012). Evaluating the Impact of Patient Recruitment and Retention Practices. Drug Information Journal. 46(5). 573–580. 20 indexed citations

13.

Agodoa, Lawrence Y., Alfonso J. Alanis, Maria Alexander-Bridges, et al.. (2007). Increasing Minority Participation in Clinical Research. Digital Repository at the University of Maryland (University of Maryland College Park). 3 indexed citations

14.

Byrne, Margaret M., Jeanne L. Speckman, Ken Getz, & Jeremy Sugarman. (2006). Variability in the Costs of Institutional Review Board Oversight. Academic Medicine. 81(8). 708–712. 23 indexed citations

15.

Getz, Ken, et al.. (2001). VBA Developer's Handbook. Medical Entomology and Zoology. 5 indexed citations

16.

Getz, Ken, et al.. (2001). Access 2002 Enterprise Developer's Handbook. 2 indexed citations

17.

Vogel, John R. & Ken Getz. (1997). Factors Driving the Increased use of Outside Contractors in Drug Development. Clinical Research and Regulatory Affairs. 14(3-4). 177–190. 4 indexed citations

18.

Getz, Ken, et al.. (1997). Access 97 developer's handbook. 2 indexed citations

19.

Getz, Ken, et al.. (1994). Microsoft Access 2 Developer's Handbook.

20.

Getz, Ken, et al.. (1994). Microsoft Access 95 developer's handbook. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact